EVALUATION OF CITALOPRAM AFFECTED THE GENERALIZED ANXIETY DISORDER PARTICIPANTS’ QUALITY OF LIFE. International Research Journal of Pharmacy, [S. l.], v. 14, n. 11, p. 21–25, 2023. DOI: 10.56802/kedfgd52. Disponível em: https://irjponline.org/index.php/irjp/article/view/3480. Acesso em: 26 may. 2026.